Open AccessP101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin's lymphoma.
Author(s) -
Mangasarova Ya.K.,
Moiseeva T.N.,
AlRadi L.S.,
Margolin O.V.,
Gorenkova L.G.,
Nesterova E.S.,
Bagova M.O.,
Fastova E.A.,
Abdurashidova R.R.,
Sarakaeva Z.T.,
Dorokhina Elena,
Kravchenko S.K.,
Magomedova A.U.,
Zvonkov E.E.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000890972.83229.41
Subject(s) - medicine , regimen , gemcitabine , vinorelbine , chemotherapy , refractory (planetary science) , nivolumab , dexamethasone , combination chemotherapy , gastroenterology , oncology , surgery , cancer , immunotherapy , cisplatin , physics , astrobiology